MoneyWorks4Me

The company's total revenue for the quarter ended June 2026 saw a slight change in the total revenue, having registered a total revenue of Rs. 57411.30 millions.A comparatively good net profit growth of 49.67% to Rs. 11151.40 millions was reported for the quarter ended June 2026 compared to Rs. 7450.60 millions of previous same quarter.Operating profit surged to 21043.80 millions from the corresponding previous quarter of 20132.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 57411.30 55948.80 2.61 57411.30 55948.80 2.61 207546.40 229774.00 -9.67
Other Income 1401.70 1037.10 35.16 1401.70 1037.10 35.16 4193.30 3791.40 10.60
PBIDT 21043.80 20132.40 4.53 21043.80 20132.40 4.53 66000.20 72168.40 -8.55
Interest 2784.80 2384.20 16.80 2784.80 2384.20 16.80 9478.40 9538.90 -0.63
PBDT 17943.70 14871.80 20.66 17943.70 14871.80 20.66 51058.40 62629.50 -18.48
Depreciation 3079.20 3109.20 -0.96 3079.20 3109.20 -0.96 13117.20 12867.40 1.94
PBT 14864.50 11762.60 26.37 14864.50 11762.60 26.37 37941.20 49762.10 -23.75
TAX 3713.10 4312.00 -13.89 3713.10 4312.00 -13.89 11707.00 7481.30 56.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 11151.40 7450.60 49.67 11151.40 7450.60 49.67 26234.20 42280.80 -37.95
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 36.65 35.98 1.86 36.65 35.98 1.86 31.80 31.41 1.25
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..